Posts

Showing posts with the label Cannabidiol

Cannabidiol Market to Surpass an Outstanding Growth

Image
  Cannabidiol  CBD is a molecule found in the cannabis sativa plant, which is commonly known as marijuana or hemp. The cannabis sativa plant contains more than 80 compounds known as cannabinoids. Cannabidiol is the most extensively utilised cannabinoid for medicinal purposes due to its absence of psychoactive effects. Cannabidiol oil is utilised in a variety of medicinal applications, including anxiety and depression therapy, stress reduction, diabetes prevention, pain relief, cancer symptom alleviation, and inflammation relief. The worldwide cannabidiol market is expected to develop at a profitable pace over the projected period, owing to the increased acceptance of CBD-based products to cure diseases. The global cannabidiol market size was estimated to be valued at US$ 3665.5 Million in 2021, and is expected to witness a CAGR of 47.3% over the forecast period (2021-2028). There is a rising need for nutrient-dense foods to help people achieve their fitness objectives and avoid pr

A recent study suggest that cannabidiol can be used to treat epilepsy

Image
  Cannabidiol  Cannabidiol is a new compound discovered by researchers that have been shown to reduce anxiety in patients suffering from social phobia. It was found that it inhibits THC-elicited paranoid symptoms. Another study also found that it inhibited the development of hippocampal-dependent memory impairment in rats. According to the journal Neuropsychopharmacology, it suppressed nitric oxide production in beta-amyloid-stimulated PC12 neurons. In addition to reducing seizure frequency and severity, Cannabidiol also reduces adverse events, such as seizures. In animal studies, it is associated with fewer adverse events and increased plasma levels. The benefits of this can be seen in humans, too, although the FDA has not evaluated it as yet. It is still necessary to do further research before recommending it for human use. A recent study published in the journal Neuropsychopharmacology reported that cannabidiol reduced the anxiety levels of patients suffering from social phobia

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides